The significance of upfront autologous stem cell transplantation for high-intermediate/high-risk stage IV diffuse large B-cell lymphoma.
Aleksei K KoviazinLarisa V FilatovaIlia S ZyuzginAnna S ArtemyevaIlia L PoliatskinDarya S BurdaStanislav A VolchenkovSvetlana S ElkhovaTatiana Yu SemiglazovaPublished in: Cancer reports (Hoboken, N.J.) (2023)
Upfront HDCT followed by auto-HSCT can increase 3-year OS and PFS and improve prognosis in DLBCL NOS, age 18-65, stage IV, IPI ≥2 patients.